Cargando…
Cytokine and reactivity profiles in SLE patients following anti-CD19 CART therapy
Chimeric antigen receptor (CAR) T cells targeting CD19(+) B cells have demonstrated efficacy in refractory systemic lupus erythematosus (SLE). Although initial clinical data suggest that anti-CD19 CAR T cell therapy is well tolerated and highly effective, the immunologic consequences of CAR T cell t...
Autores principales: | , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10514439/ https://www.ncbi.nlm.nih.gov/pubmed/37744005 http://dx.doi.org/10.1016/j.omtm.2023.08.023 |